Skip to main content

2020 Main Programming Package

The Main Programming Package includes general sessions presented at the 2020 NCS Annual Meeting. It does not include workshop sessions.

Main Programming Bundle
Member: $300
Non-Member: $375


Once purchased, you will have access to the content for a period of two years.

The learner must view the entire recording of the presentation selected and answer a series of assessment questions. Note: Participants are not allowed to claim credit for presentations viewed under an identical title and learning objectives delivered live online or as part of another on-demand activity.

Upon successful completion of the assessment questions and evaluation, a certificate will be generated. You will have the option to download the Certificate and CE Attestation for your records, and it will also continue to be available within your profile. NCS provides completion information to the accrediting agency on a monthly basis. All content is the copyrighted material of the ©2020 Neurocritical Care Society.

  • An internet connection speed of at least 4Mbps and a modern browser
  • Modern browsers have a built in PDF reader which would be necessary for you to view your completion certificates

CME OVERVIEW (click to view)

Access to this course is valid for 2 years from the date of purchase.
Release Date: November 9, 2020
Expiration Date: November 1, 2023

Target Audience
This activity is designed for physicians, nurses, pharmacists and other healthcare specialists, including residents/fellows, who care for patients requiring neurocritical care.

Learning Objectives
  • Discern clinical practice and challenges for neurocritical care patients around the globe.
  • Identify best practice strategies and clinical challenges when caring for neurocritical care patients with traumatic brain injury, intracranial hemorrhage, stroke, and central nervous system infections.
  • Examine ongoing clinical trials, controversies in clinical practice and end-of-life decision-making strategies in the care of patients with neurologic injury.
  • Determine opportunities to use neuromonitoring, informatics, genomics, and quality metrics in the neuroscience ICU to improve quality of care.
  • Identify the challenges and strategies for prognostication and management of critically ill patients with hypoxic-ischemic encephalopathy, near-brain dead conditions, and post-ICU syndrome. 

Activity Goal
This activity is designed to address the following core and team competencies:
Patient Care, Medical Knowledge, Professionalism, Employ evidence-based practice, Value & Ethics, Team & Teamwork, Interprofessional Collaboration, and Interprofessional Communication.


The provider adheres to accreditation requirements regarding industry support of continuing medical education. Disclosure of the planning committee and faculty's commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. - All provider employees and activity planners in control of content have indicated that they have no relevant financial relationships to disclose.

Disclosure Summary

The following contributors have all indicated that they have No Relevant Financial Relationships to Disclose: Ozan Akca, MD; Hosam Al-Jehani, MBBS; Charles Andrews, MD; Mark Angle, MD; Michael Armahizer, PharmD; Marie Baldisseri, MD; Arianna Barnes, RN; Megan Barra, PharmD; Janet Bettger, ScD; Karen Bloch, MD; Jordan Bonomo, MD; Michael Bradshaw, MD; Lourdes Carhuapoma, MS; Sung-Min Cho, DO; Fern Cudlip, MSN; Vikram Dhawan, MD; Jamil Dibu, MD; Shane English, MD; Salia Farrokh, PharmD; Emmaculate Fields, NP; Shivani Ghoshal, MD; Brian Gilbert, PharmD; Jamie LaBuzetta, MD; Kerri LaRovere, MD; William Lombardi, DNP; George Lopez, MD, PhD; Dea Mahanes, DNP, RN; Lindsay Marchetti, MS,;PA-C; Stephan A. Mayer, MD; Diane McLaughlin, DNP; Jorge H. Mejia-Mantilla, MD; Melissa Motta, MD; Jeffrey Mucksavage, PharmD; Susanne Muehlschlege, MD; Santosh Murthy, MD; Jensen Ng, MBBS; Christa O’Hana Noblezza, MD; Alia O’Meara, MD; Amay Parikh, MD; Venkatakrishna Rajajee, MBBS; Alexandra Richards, DNP; Chiara Robba, PhD; Vishank Shah, MD; Lori Shutter, MD; Keaton Smetana, PharmD; Zachary Threlkeld, MD; Jessica Traeger, PharmD, BCCCP; Lauren Treat, MD; Glenn J. R. Whitman, MD; Cyndi Williams, MD

Relevant Disclosures
Last First Suffix Commercial Interest For what role?
Alexander Sheila PhD, RN University of Pittsburgh Medical Center, Shadyside Hospital

University of Pittsburgh Medical Center, Passavant Hospital

National Institutes of Health/National Institute of Aging

Veterans Administration
NIH/National Institute of Aging and NIH/National Cancer Institute
Management of research study: Improving Sleep in the hospital.

Nursing Research Consulting, Evidence Based Practice Advisory Committee

PI of research study: Inflammatory gene methylation and delirium in ICU patients.

Grant review panel‐ Neurobiology C
Honorariums for serving on grant review panels.
Claassen Jan MD iCE Neurosystems
Scientific advisory board
Foreman Brandon MD UCB Pharma Inc

Speakers Bureau, Consulting
Grant Funding

Garvin Rachel MD Genetech, A Member of the RocheGroup
Guilliams Kristin MD Acer Therapeutics FDA Panelist
Hanley Daniel MD NIH
Fees for consulting
Lele Abhijit MBBS, MD
Aqueduct Critical Care
LifeCenter Northwest
Clinical trial
Medical Advisor
Meyer Kimberly

Board of directors, speaker
Rosand Jonathan MD Boehringer Ingelheim Consulting
Shoamanesh Ashkan MD Portola Pharmaceuticals
Daiichi Sankyo Ltd.
Servier Canada Inc.

Bristol‐Myers Squibb

Bayer AG
PI, advisory board, Speaker's Bureau

Research funding; PI

Research Funding, Honoraria; PI, advisory board
Souter Michael MB Lifecenter Northwest
Medical director
Venkatasubramanian Chitra MBBS Ceribell Consultant

Non-Endorsement Statement

The provider verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. The provider does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

In support of improving patient care, this activity has been planned and implemented by Cine-Med, Gladwell CME and the Neurocritical Care Society. Cine-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Ciné-Med designates this live enduring material for a maximum of 22.5 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is approved for 22.5 contact hours for nurses.

This activity has been accredited for 2.25 CEU (22.5 credit hours) of continuing education credit.

All other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for activities designated for AMA PRA Category 1 Credits ™, consult your professional licensing board.

Commercial Support

This activity is being provided independent of industry support.

Please click here to view the NCS Legal Disclaimer for the NCS Annual Meeting content.